122 related articles for article (PubMed ID: 30193020)
1. Surveillance of Wisconsin Organisms for Trends in Antimicrobial Resistance and Epidemiology: Introduction to the Program and Summary of 2016 Geographic Variation.
Munson E; Hueppchen E; Zeman H
WMJ; 2018 Aug; 117(3):116-121. PubMed ID: 30193020
[TBL] [Abstract][Full Text] [Related]
2.
Schulte RH; Munson E
Clin Med Res; 2019 Dec; 17(3-4):72-81. PubMed ID: 31582419
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of Fluoroquinolone Resistance in Wisconsin: Geographic Variation and Impact of Revised CLSI Breakpoints.
Lazzerini G; Lavey SC; Fox BC; Munson E
Clin Med Res; 2022 Jun; 20(2):81-88. PubMed ID: 35086853
[No Abstract] [Full Text] [Related]
4. Surveillance of Wisconsin Antibacterial Susceptibility Patterns.
Munson E; Block TK; Bowles EJ; Costello M; Dern R; Fritsche TR; Helgesen MA; Kropp JL; Podzorski RP; Siebers K; Simmons B; Smith MA; Spray F; Van TT; Warshauer DM
WMJ; 2016 Feb; 115(1):29-36. PubMed ID: 27057577
[TBL] [Abstract][Full Text] [Related]
5. Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents.
Fedler KA; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):427-36. PubMed ID: 16938419
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of Wisconsin Organisms for Trends in Antimicrobial Resistance and Epidemiology (SWOTARE): 2018-2019 Report on
Reynoso A; Munson E
Clin Med Res; 2021 Sep; 19(3):123-131. PubMed ID: 34531269
[No Abstract] [Full Text] [Related]
7. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).
Sader HS; Farrell DJ; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):443-8. PubMed ID: 24492025
[TBL] [Abstract][Full Text] [Related]
8. Changes in
Munson E; Lavey SC; Lasure MR; Fox BC
Clin Med Res; 2022 Dec; 20(4):185-194. PubMed ID: 36581396
[No Abstract] [Full Text] [Related]
9. Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011-2013.
Hayajneh WA; Hajj A; Hulliel F; Sarkis DK; Irani-Hakimeh N; Kazan L; Badal RE
Int J Infect Dis; 2015 Jun; 35():56-61. PubMed ID: 25917963
[TBL] [Abstract][Full Text] [Related]
10. Comparison of emergency department to hospital antibiograms: Influence of patient risk factors on susceptibility.
Miller JL; George A; Kozmic SE; Beganovic M; Wieczorkiewicz SM
Am J Emerg Med; 2020 Jun; 38(6):1153-1158. PubMed ID: 31495521
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance in 11 hospitals in Puerto Rico: results of an antimicrobial resistance management (ARM) program.
Gums JG; Boatwright DW; Totti N; Martinez M
P R Health Sci J; 2007 Sep; 26(3):181-9. PubMed ID: 18035809
[TBL] [Abstract][Full Text] [Related]
12. [Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].
Acuner IC; Bayramoğlu G; Birinci A; Cekiç Cihan C; Bek Y; Durupınar B
Mikrobiyol Bul; 2011 Jul; 45(3):411-21. PubMed ID: 21935774
[TBL] [Abstract][Full Text] [Related]
13. Results of the 1997 SENTRY Antimicrobial Surveillance Program in Three Brazilian Medical Centers.
Sader HS; Sampaio JL; Zoccoli C; Jones RN
Braz J Infect Dis; 1999 Apr; 3(2):63-79. PubMed ID: 11098193
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Susceptibility Monitoring of Bacterial Pathogens Isolated from Urinary Tract Infections in Dogs and Cats Across Europe: ComPath Results.
Moyaert H; Morrissey I; de Jong A; El Garch F; Klein U; Ludwig C; Thiry J; Youala M
Microb Drug Resist; 2017 Apr; 23(3):391-403. PubMed ID: 28384093
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
[TBL] [Abstract][Full Text] [Related]
16. Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.
Mutnick AH; Turner PJ; Jones RN
J Chemother; 2002 Jun; 14(3):253-8. PubMed ID: 12120879
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance.
Viray M; Linkin D; Maslow JN; Stieritz DD; Carson LS; Bilker WB; Lautenbach E
Infect Control Hosp Epidemiol; 2005 Jan; 26(1):56-62. PubMed ID: 15693409
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from Intensive Care Units in The Netherlands, 1998-2005.
Oudhuis GJ; Verbon A; Hoogkamp-Korstanje JA; Stobberingh EE;
Int J Antimicrob Agents; 2008 Jan; 31(1):58-63. PubMed ID: 17961989
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibility of bacterial isolates from the equine respiratory tract to trimethoprim, sulfadoxine, sulfadimethoxine and combinations of these compounds].
Fey K; Schmid P
Tierarztl Prax; 1995 Apr; 23(2):148-54. PubMed ID: 7624856
[TBL] [Abstract][Full Text] [Related]
20. Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals.
Adam HJ; Baxter MR; Davidson RJ; Rubinstein E; Fanella S; Karlowsky JA; Lagacé-Wiens PR; Hoban DJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i31-7. PubMed ID: 23587776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
